3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
103
Lymphoma
68
Lymphoma, Large B-Cell, Diffuse
49
Precursor Cell Lymphoblastic Leukemia-Lymphoma
41
Sarcoma
33
Lymphoma, Non-Hodgkin
29
Hodgkin Disease
28
Leukemia
23
Burkitt Lymphoma
22
Neoplasms
19
Lymphoma, Mantle-Cell
18
Triple Negative Breast Neoplasms
15
Multiple Myeloma
15
Lymphoma, Follicular
15
Lymphoma, B-Cell
14
Lymphoma, Large-Cell, Anaplastic
12
Carcinoma, Hepatocellular
12
Breast Neoplasms, Male
11
Neuroblastoma
10
Recurrence
9
Ovarian Neoplasms
9
Neoplasm Metastasis
9
Inflammatory Breast Neoplasms
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, T-Cell, Peripheral
8
Lymphoma, T-Cell
8
Osteosarcoma
7
Fallopian Tube Neoplasms
7
Urinary Bladder Neoplasms
6
Liposarcoma
6
Interventions
Peripheral Blood Stem Cell Transplantation
12
Rituximab
9
Tacrolimus
8
Mycophenolic Acid
8
fludarabine phosphate
7
Cyclophosphamide
7
Whole-Body Irradiation
6
Cyclosporine
5
Radiotherapy
4
Methotrexate
4
Granulocyte Colony-Stimulating Factor
4
Filgrastim
4
Busulfan
4
Antilymphocyte Serum
4
immunotoxin HA22
3
fludarabine
3
Etoposide
3
Dexamethasone
3
Calcium Dobesilate
3
plerixafor
2
merphos
2
Therapeutics
2
Sirolimus
2
Ondansetron
2
Melphalan
2
Ipilimumab
2
Flow Cytometry
2
Diphenhydramine
2
Darbepoetin alfa
2
Cord Blood Stem Cell Transplantation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Hairy Cell
×
Doxorubicin
×
Clear all
No trials found.